Pre-Existing Autoimmune Disease And The Risk For Cardiovascular And Non-Cardiovascular Immune Mediated Adverse Events With Immune Checkpoint Inhibitors

Charlotte Lee,Zsofia D. Drobni,Amna Zafar,Raza M. Alvi,Sean P. Murphy,Ramya C. Mosarla,Paula K. Rambarat, Sarah B. Hartmann,Hannah K. Gilman,Leyre Zubiri,Vineet K. Raghu,Ryan J. Sullivan,Daniel A. Zlotoff,Alexander Faje,Kerry L. Reynolds,Tomas G. Neilan

Circulation（2020）

引用 0|浏览29

暂无评分

摘要

Introduction: The use of immune checkpoint inhibitors (ICIs) is associated with an increase in cardiovascular events. The mechanism is likely related to immune activation and inflammation. Patients...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要